Oncternal Therapeutics Inc - GTU

Sector: No information yet · Industry: No information yet
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2024 · Q2 2024
Value (USD)
Total reported value ($000)
$396K
QoQ value delta ($000)
-$2.242M (-84.99%)
Implied price effect (QoQ)
-82.84%
Shares
Total shares
304,663
QoQ shares delta
-43,537 (-12.5%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (GTU)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2024)

Top 25 only Full list
Early Q2 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 184 139,884 0.0%
MILLENNIUM MANAGEMENT LLC 80 61,205 0.0%
BlackRock, Inc. 52 39,706 0.0%
GEODE CAPITAL MANAGEMENT, LLC 34 25,879 0.0%
RENAISSANCE TECHNOLOGIES LLC 23 17,905 0.0%
MORGAN STANLEY 18 14,152 0.0%
Tower Research Capital LLC (TRC) 3 2,822 0.0%
JPMORGAN CHASE & CO 1 1,111 0.0%
UBS Group AG 1 1,221 0.0%
BANK OF AMERICA CORP /DE/ 0 22 0.0%
WELLS FARGO & COMPANY/MN 0 408 0.0%
DANSKE BANK A/S 0 1 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 182 0.0%
OSAIC HOLDINGS, INC. 0 150 0.0%
Steward Partners Investment Advisory, LLC 0 15 0.0%